Seven Eight Capital, LP Laboratory Corp Of America Holdings Transaction History

Seven Eight Capital, LP

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$209.01 - $232.56 $1.24 Million - $1.38 Million	5,917 New	5,917 $1.29 Million
Q1 2022 May 11, 2022	SELL	$259.82 - $298.18 $804,142 - $922,867	-3,095 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$271.6 - $314.21 $840,602 - $972,479	3,095 New	3,095 $972,000
Q3 2021 Nov 15, 2021	SELL	$274.82 - $308.34 $457,025 - $512,769	-1,663 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$251.87 - $278.14 $418,859 - $462,546	1,663 New	1,663 $459,000
Q3 2020 Nov 16, 2020	SELL	$167.03 - $201.3 $334,060 - $402,600	-2,000 Closed	0 $0
Q2 2020 Aug 06, 2020	BUY	$113.31 - $182.44 $226,620 - $364,880	2,000 New	2,000 $332,000
Q2 2019 Aug 12, 2019	SELL	$144.16 - $172.9 $3.45 Million - $4.13 Million	-23,911 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$123.7 - $156.3 $1.95 Million - $2.47 Million	15,800 Added 194.8%	23,911 $3.66 Million
Q4 2018 Feb 14, 2019	BUY	$120.82 - $174.09 $979,971 - $1.41 Million	8,111 New	8,111 $1.03 Million

1.87M

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $22.2B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

Get notified when there are updates to the investment portfolio of Seven Eight Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Seven Eight Capital, LP with notifications on news.